BioRestorative Therapies Provides First Quarter 2024 Business Update
May 14, 2024 16:10 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based...
Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
November 01, 2023 05:00 ET
|
AKAMPION
- Seasoned business development professional joins from Lonza PRESS RELEASE. Cologne, Germany — November 1, 2023 - Cellbox Solutions GmbH, a leading provider of live cell logistics solutions for...
Autologous Cell Therapy Market to Hit USD 33.1 Billion by 2032; Amid Surging Demand From Personalized Treatments - Market.us
October 03, 2023 08:59 ET
|
Market.Us
New York, Oct. 03, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the Autologous Cell Therapy Market size is expected to be worth around USD 33.1 Billion by 2032 from USD 5.5 Billion in 2022,...
Outpace Bio to Present New Data on OutSmart™ IL-2/15, a CAR T Cell-Produced Designed Cytokine with Tumor-Localized Immune Cell Activity, at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 18, 2023 08:00 ET
|
Outpace Bio
Seattle, WA, May 18, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced it will...
Outpace Bio, a Leader in Protein Design for Cell Therapy, Strengthens Executive Leadership Team with Key Appointments
May 04, 2023 08:00 ET
|
Outpace Bio
Seattle, WA, May 04, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies, today announced two key leadership appointments....
Austrianova Secures Investment from Checkmate Capital
March 01, 2023 12:00 ET
|
SG Austria Pte Ltd
SINGAPORE, March 02, 2023 (GLOBE NEWSWIRE) -- SG Austria (“Austrianova”), a leading provider of cell biological products and services, today announced that Checkmate Capital Group (“Checkmate...
BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
November 16, 2022 08:56 ET
|
BioRestorative Therapies, Inc
Melville, NY., Nov. 16, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (Nasdaq: BRTX), a clinical stage company focused on the development of...
BioRestorative Therapies to Ring Nasdaq Stock Market Closing Bell
February 07, 2022 07:45 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Feb. 07, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical-stage company focused on stem cell-based therapies,...
Mesoblast Lists On Nasdaq
November 15, 2015 18:46 ET
|
Mesoblast
MELBOURNE, Australia and NEW YORK, Nov. 15, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (NASDAQ:MESO) today announced it had listed on the Nasdaq Global Market on 13 November under the symbol...